AN2 Therapeutics Inc ANTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:02 PM EDT
2.59UNCH (UNCH)
Volume
880
Close
2.59quote price arrow up+0.03 (+1.17%)
Volume
126,460
52 week range
2.20 - 22.22
Loading...
  • Open2.60
  • Day High2.61
  • Day Low2.45
  • Prev Close2.56
  • 52 Week High22.22
  • 52 Week High Date01/10/24
  • 52 Week Low2.20
  • 52 Week Low Date04/26/24

Key Stats

  • Market Cap77.257M
  • Shares Out29.83M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta-0.05
  • YTD % Change-87.36

KEY STATS

  • Open2.60
  • Day High2.61
  • Day Low2.45
  • Prev Close2.56
  • 52 Week High22.22
  • 52 Week High Date01/10/24
  • 52 Week Low2.20
  • 52 Week Low Date04/26/24
  • Market Cap77.257M
  • Shares Out29.83M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta-0.05
  • YTD % Change-87.36

RATIOS/PROFITABILITY

  • EPS (TTM)-2.82
  • P/E (TTM)-0.92
  • Fwd P/E (NTM)-1.01
  • EBITDA (TTM)-69.635M
  • ROE (TTM)-58.83%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On AN2 Therapeutics Inc

 

Profile

MORE
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Its initial candidate is epetraborole, which is a potential once-daily, oral treatment with a novel mechanism of action for patients with non-tuberculous mycobacterial (NTM) lung disease, a rare, chronic, and progressive infectious disease caused by bacteria known as mycobacteria, which...
Joseph Zakrzewski
Non-Executive Chairman of the Board, Co-Founder, Independent Director
Eric Easom
President, Chief Executive Officer, Co-Founder, Director
Lucy Day
Chief Financial Officer, Principal Accounting Officer
Address
1800 El Camino Real, Suite D
Menlo Park, CA
94025-3069
United States

Top Peers

SYMBOLLASTCHG%CHG
LABP
Landos Biopharma Inc
22.15-0.09-0.38%
ANEB
Anebulo Pharmaceuticals Inc
2.95UNCHUNCH
ENTX
Entera Bio Ltd
2.39+0.23+10.65%
CRVS
Corvus Pharmaceuticals Inc
1.91-0.01-0.52%
SLS
Sellas Life Sciences Group Inc
1.29-0.04-3.01%